Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 6,193 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Medication Group Clear all

Conditions: Type 2 Diabetes Mellitus
Interventions: WellStart; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Cryptococcal Infection, Cryptococcal Pneumonia, Pulmonary Cryptococcosis, Cryptococcal Meningitis, Cryptococcosis
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 1993
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hypercholesterolaemia
Interventions: Alirocumab SAR236553, Current auto-injector device (AI), New auto-injector device (SYDNEY), Atorvastatin, Rosuvastatin; Drug · Device
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 13
States / cities: Los Angeles, California • Jacksonville, Florida • Ponte Vedra, Florida + 8 more

Conditions: HIV, Risk Reduction Behavior
Interventions: MILE intervention; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older · Male only
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Kidney Transplant
Interventions: TAKE IT Strategy; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years and older
Enrollment: 449 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Scottsdale, Arizona • Chicago, Illinois

Conditions: Diabetic Kidney Disease, Uncontrolled Hypertension
Interventions: Telehealth; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Parkinson's Disease
Interventions: gait and balance training program; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chronic Pain
Interventions: Chronic Disease Self-Management Program (CDSMP) for chronic pain in Spanish, Remote feedback active group, Remote feedback control group; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 40 Years to 80 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Asthma
Interventions: Pressurized Metered-Dose Inhaler; Device
Lead sponsor: Philips Respironics; Industry
Eligibility: 5 Years to 8 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Ocular Hypertension, Open Angle Glaucoma
Interventions: Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution, Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution; Drug
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 30
States / cities: Dothan, Alabama • Phoenix, Arizona • Garden Grove, California + 25 more

Conditions: Lupus Erythematosus
Interventions: ABT-199, Placebo; Drug · Other
Lead sponsor: AbbVie (prior sponsor, Abbott); Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 11
States / cities: Clearwater, Florida • DeBary, Florida • Miami, Florida + 7 more

Conditions: Substance Use Disorders, Overdose, Opioid Use Disorder, Alcohol Use Disorder
Interventions: Substance Misuse Assistance Response Team (SMART), Usual Care Group; Behavioral · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Bone Marrow Transplantation
Interventions: Ronacaleret (100mg tablet), Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Stem cell (HPC) implantation, Stereotactic surgical device; Biological · Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HIV, Sexual Risk, Sexually Transmitted Diseases, Substance Abuse, Violence, Victimization
Interventions: Young Women's CoOp, Staying Healthy and Eating Well; Behavioral
Lead sponsor: RTI International; Other
Eligibility: 16 Years to 19 Years · Female only
Enrollment: 237 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Durham, North Carolina • Research Triangle Park, North Carolina

Conditions: Pectus Excavatum, Pain, Postoperative
Interventions: Use of PCA, Use of ESB for postoperative pain control after MIRPE, Use of INC for postoperative pain control after MIRPE; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 21 Years
Enrollment: 158 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Postdural Puncture Headache
Interventions: Morphine, Sterile normal saline; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 4
States / cities: Newark, New Jersey • New York, New York

Conditions: Type 2 Diabetes, Hypertension, Obesity and Obesity-related Medical Conditions, Heart Disease
Interventions: Nutrition Matters; Behavioral
Lead sponsor: Winston Salem State University; Other
Eligibility: 35 Years to 64 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Patient Compliance, Medication Adherence, Medication Non-Adherence
Interventions: Information prescriptions; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 3,940 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 3
States / cities: Baltimore, Maryland • Columbia, Maryland

Conditions: Pertrochanteric Fracture
Interventions: Marcaine, Duramorph , ketorolac, Bupivacaine (Marcaine), General Anesthetics; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Allergic Conjunctivitis
Interventions: contact lens with ketotifen, contact lens; Device
Lead sponsor: Vistakon Pharmaceuticals; Industry
Eligibility: 8 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2009
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Clinical Decision Making, Nonarthritic Hip Disease
Interventions: Interdisciplinary Evaluation for Nonarthritic Hip Disease, Posture and Movement Training, Treatment-of-choice; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Migraine Disorders
Interventions: Combination Product (sumatriptan succinate / naproxen sodium), RELPAX(eletriptan) 40mg Tablet; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Healthy Adults
Interventions: Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole, Rifampin; Drug
Lead sponsor: Mirati Therapeutics Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

WellStart Reboot Study

Fungal Infection Susceptibility

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

The HJ MILE HIV Prevention Intervention for Post-incarcerated Men

Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial

Integrated Population Program for Diabetic Kidney Disease

Computer-Based Balance Training for People With Parkinson's Disease

Escoge Salud (Choose Health): a Chronic Pain Self-Management Program in Middle to Older Age Hispanic Americans

Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

Emergency Medicine Peer Outreach Worker Engagement for Recovery

An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers

CNS10-NPC-GDNF for the Treatment of ALS

Young Women's CoOp Study

Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum

2 Dose Neuraxial Morphine for Prevention of PDPH

NUTRITION MATTERS: A Food is Medicine Intervention for African-American Adults With Multiple Chronic Conditions

Impact of Information Prescriptions on Medication Adherence in Emergency Department (ED) Patients

Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Nonarthritic Hip Disease Evaluation And Treatment

TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine

PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.